CALLAN JMB Amends S-1, Adds Equity Purchase & Registration Rights Pacts

TL;DR

**CJMB's S-1/A is a procedural step, but the new equity and registration agreements hint at an imminent capital raise, making it a cautious 'watch' for potential investors.**

AI Summary

CALLAN JMB INC. (CJMB) filed an S-1/A on September 19, 2025, primarily as an exhibits-only amendment to its initial S-1 filing (File No. 333-289849). This amendment introduces two new exhibits: an Equity Purchase Agreement dated July 24, 2025, and a Registration Rights Agreement also dated July 24, 2025, both involving an unnamed 'Investor'. The filing also includes an updated Opinion of Sichenzia Ross Ference Carmel LLP and a List of Subsidiaries. The company, incorporated in Nevada, maintains its principal executive offices at 244 Flightline Drive, Spring Branch, Texas 78070-6241. Key management, including CEO Wayne Williams and Interim CFO Shannon Badger, signed the amendment on September 19, 2025. The S-1/A indicates that the remainder of the original registration statement is unchanged, suggesting no new financial figures or significant business model shifts were disclosed in this specific amendment. The company is classified as a 'Smaller reporting company' and an 'Emerging growth company'.

Why It Matters

This S-1/A filing signals CALLAN JMB INC.'s progression towards its public offering, with the inclusion of an Equity Purchase Agreement and a Registration Rights Agreement indicating a potential capital infusion from an investor. For investors, this suggests a step closer to liquidity and provides insight into the terms of early investment, though specific dollar amounts are not disclosed in this amendment. Employees and customers might see this as a sign of stability and growth, potentially enhancing the company's competitive position in its sector by securing funding. The competitive landscape will be watching for the full S-1 to understand CJMB's market strategy and financial health.

Risk Assessment

Risk Level: medium — The risk level is medium because this is an exhibits-only filing, meaning no new financial data or comprehensive business updates were provided. While the inclusion of an Equity Purchase Agreement and Registration Rights Agreement suggests progress towards an offering, the lack of specific financial details in this amendment (e.g., the amount of equity purchased or the investor's identity) prevents a full assessment of the company's current financial health or the dilution impact. The company is also an 'Emerging growth company' and 'Smaller reporting company', which often entails higher inherent risks due to less operational history and resources.

Analyst Insight

Investors should view this S-1/A as a procedural update rather than a substantive financial disclosure. Focus on the original S-1 filing (File No. 333-289849) for comprehensive business and financial details. Monitor future amendments for the full terms of the Equity Purchase Agreement and the identity of the investor, as these will be crucial for evaluating the company's valuation and future capital structure.

Executive Compensation

Key Numbers

• 333-289849 — Registration No. (Original S-1 filing number for CALLAN JMB INC.)
• September 19, 2025 — Filing Date (Date of S-1/A amendment filing)
• 244 Flightline Drive — Principal Executive Office Address (Location of CALLAN JMB INC.'s headquarters)
• (830) 438-0395 — Telephone Number (Contact number for CALLAN JMB INC.)
• 7389 — Primary SIC Code (Standard Industrial Classification Code Number for the registrant)
• 99-0931141 — I.R.S. Employer Identification Number (Tax identification number for CALLAN JMB INC.)
• Nevada — State of Incorporation (Jurisdiction where CALLAN JMB INC. is incorporated)
• July 24, 2025 — Equity Purchase Agreement Date (Date of the newly filed Equity Purchase Agreement)
• July 24, 2025 — Registration Rights Agreement Date (Date of the newly filed Registration Rights Agreement)
• February 2, 2024 — Reorganization Agreement Date (Date of the Reorganization Agreement and Plan of Share Exchange)

Key Players & Entities

• CALLAN JMB INC. (company) — Registrant filing S-1/A
• Wayne Williams (person) — Chief Executive Officer, President, and Chairman of the Board
• Shannon Badger (person) — Interim Chief Financial Officer
• Sichenzia Ross Ference Carmel LLP (company) — Legal counsel providing opinion
• Sullivan & Worcester LLP (company) — Legal counsel
• Coldchain Technology Services, LLC (company) — Subsidiary involved in Reorganization Agreement
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for filing
• David J. Croyle, M.D. (person) — Chief Medical Officer and signatory
• Eric L. Kash (person) — Executive Vice President, Director, and signatory
• July 24, 2025 (date) — Date of Equity Purchase Agreement and Registration Rights Agreement

FAQ

Risk Factors

• Equity Purchase and Registration Rights Agreements [medium — legal]: The filing includes new exhibits for an Equity Purchase Agreement and a Registration Rights Agreement, both dated July 24, 2025, with an unnamed 'Investor'. The specifics of these agreements, including the terms of the equity purchase and the rights granted to the investor, could introduce significant financial and operational risks if not structured favorably for Callan JMB Inc.
• SEC Registration Process [medium — regulatory]: As a company undergoing the registration process, Callan JMB Inc. is subject to ongoing SEC review and compliance requirements. Delays or issues in the effectiveness of the registration statement could impact the company's ability to raise capital and conduct its business as planned.
• Reliance on Existing Agreements [low — operational]: The S-1/A amendment incorporates by reference numerous prior agreements, including professional services agreements with the City of Chicago Department of Public Health and various lease and sublease agreements. The performance and continuation of these agreements are critical to operations, and any disruption could negatively impact the business.

Industry Context

Callan JMB Inc. appears to be operating in a sector that involves technology services, potentially related to cold chain logistics given the reference to Coldchain Technology Services, LLC. The industry context is not detailed in this S-1/A amendment, but the company's classification as a smaller reporting and emerging growth company suggests it is likely a relatively young or developing entity within its market.

Regulatory Implications

The primary regulatory implication of this S-1/A filing is the continuation of the SEC registration process. The addition of new material agreements like the Equity Purchase Agreement and Registration Rights Agreement means these will be subject to SEC scrutiny. Compliance with securities laws and disclosure requirements remains paramount.

What Investors Should Do

1. Review the newly filed Equity Purchase Agreement and Registration Rights Agreement.
2. Monitor future filings for financial performance and updates.
3. Assess the implications of the 'Emerging Growth Company' and 'Smaller Reporting Company' status.

Key Dates

• 2025-09-19: Filing of S-1/A Amendment No. 1 — This amendment is primarily an exhibits-only filing, indicating updates to contractual agreements rather than new financial disclosures. It signals ongoing efforts in the registration process.
• 2025-07-24: Equity Purchase Agreement and Registration Rights Agreement executed — These agreements with an unnamed 'Investor' are newly filed exhibits. They are crucial as they likely pertain to the financing or structure of the company's public offering and future obligations.
• 2024-02-02: Reorganization Agreement and Plan of Share Exchange — This agreement, referencing Coldchain Technology Services, LLC ('CTS'), outlines a significant corporate restructuring event that forms the basis for the current entity and its assets.
• 2024-10-15: Employment Agreement for Wayne Williams — This agreement, along with others for key executives, establishes the terms of employment for management, which is critical for operational continuity and leadership during the registration and post-IPO phases.

Glossary

S-1/A

An amendment to a Form S-1 registration statement filed with the U.S. Securities and Exchange Commission (SEC). It is used to update or correct information previously filed in the original S-1. (This filing is an S-1/A, indicating Callan JMB Inc. is amending its initial registration statement, in this case, primarily to add exhibits.)

Equity Purchase Agreement

A contract between a buyer and a seller that sets forth the terms and conditions of the sale of equity (shares) in a company. (A new Equity Purchase Agreement dated July 24, 2025, has been filed, suggesting a transaction involving the purchase of Callan JMB Inc.'s equity by an investor.)

Registration Rights Agreement

An agreement that grants certain rights to holders of securities, typically related to the registration of their shares for public sale. (A new Registration Rights Agreement dated July 24, 2025, has been filed, indicating that the unnamed investor has been granted rights concerning the registration of their securities.)

Smaller reporting company

A company that meets certain criteria regarding public float and annual revenue, allowing it to file scaled-down disclosure documents with the SEC. (Callan JMB Inc. is classified as a smaller reporting company, which impacts its reporting obligations.)

Emerging growth company

A company that has total annual gross revenues of less than $1.235 billion during its most recently completed fiscal year. These companies are allowed to take advantage of certain regulatory accommodations. (Callan JMB Inc. is classified as an emerging growth company, indicating it may benefit from extended transition periods for accounting standards and other regulatory relief.)

Reorganization Agreement and Plan of Share Exchange

A legal document outlining the terms and conditions for reorganizing a company, often involving the exchange of shares to consolidate entities or prepare for a public offering. (This agreement, dated February 2, 2024, is a foundational document for Callan JMB Inc.'s current structure, involving Coldchain Technology Services, LLC.)

Year-Over-Year Comparison

This S-1/A filing is an exhibits-only amendment and does not contain updated financial figures or operational metrics compared to the initial S-1 filing. The primary change is the addition of the Equity Purchase Agreement and Registration Rights Agreement, both dated July 24, 2025, indicating new contractual developments. The remainder of the registration statement is unchanged, meaning no year-over-year comparisons of revenue, margins, or debt can be made from this specific amendment.

Filing Documents

• forms-1a.htm (S-1/A) — 85KB
• ex10-11.htm (EX-10.11) — 339KB
• ex10-12.htm (EX-10.12) — 144KB
• 0001493152-25-014158.txt ( ) — 568KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Spring Branch, Texas, on September 19, 2025. CALLAN JMB INC. By: /s/ Wayne Williams Wayne Williams Chief Executive Officer, President, and Chairman of the Board Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. SIGNATURE TITLE DATE /s/ Wayne Williams Chief Executive Officer, President, and Chairman of the Board September 19, 2025 Wayne Williams (Principal Executive Officer) and Director /s/ Shannon Badger Interim Chief Financial Officer September 19, 2025 Shannon Badger (Principal Financial and Accounting Officer) /s/ David J. Croyle, M.D. Chief Medical Officer September 19, 2025 David J. Croyle, M.D. /s/ Eric L. Kash Executive Vice President, and Director September 19, 2025 Eric L. Kash /s/ Mark Meller Director September 19, 2025 Mark Meller /s/ Gerald Dial Director September 19, 2025 Gerald Dial /s/ Liberty Duke Director September 19, 2025 Liberty Duke II-3

View Full Filing

View this S-1/A filing on SEC EDGAR